Shree Hari Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHREE HARI INTL
SHREE HARI INTL has three approved drugs.
Drugs and US Patents for Shree Hari Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shree Hari Intl | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | LOTION;TOPICAL | 070274-001 | Aug 12, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Shree Hari Intl | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 202071-001 | Dec 28, 2012 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Shree Hari Intl | ETODOLAC | etodolac | TABLET;ORAL | 074846-001 | Feb 28, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

